NCT05046184 Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets Status COMPLETED Phase PHASE2
NCT05045378 Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression Status COMPLETED Phase PHASE4
NCT05041361 HypErthermia as an Additional Treatment for the Biology and Experience of Depression Status COMPLETED Phase NA
NCT05030623 The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT05028738 Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety Status RECRUITING Phase NA
NCT05024149 Assessing the Impact of Electroacupuncture on Facial Thermal Characteristics of Major Depressive Disorder Patients Based on Infrared Thermal Imaging Technology Status UNKNOWN Phase NA
NCT05017311 Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) Status RECRUITING Phase PHASE4
NCT05016050 Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) Status COMPLETED Phase NA
NCT05009511 MRI Markers of Feedback Timing During Learning in Individuals with TBI with and Without Clinical Depression Status RECRUITING Phase NA
NCT04990687 Vagal Nerve Stimulation for Treatment Resistant Major Depression Status COMPLETED Phase NA
NCT04986124 Quality of Life in Chinese Working and School Age Population With MDD Status UNKNOWN Phase N/A
NCT04985942 Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT04981561 Safety and Tolerability of Zelquistinel in Normal Human Volunteers Status COMPLETED Phase PHASE1
NCT04977856 Efficacy and Cost-effectiveness of Internet-delivered CBT for Adolescents with Depression Status ACTIVE_NOT_RECRUITING Phase NA
NCT04975724 Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder Status RECRUITING Phase PHASE4
NCT04975100 Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE4